Literature DB >> 8864444

Clonal predominance of cytomegalovirus-specific CD8+ cytotoxic T lymphocytes in bone marrow recipients.

H Dolstra1, E Van de Wiel-van Kemenade, T De Witte, F Preijers.   

Abstract

After lymphocyte-depleted BMT, CD8+ T cells have been expanded to or above normal levels in 45% of the recipients within 3 months. The mechanisms underlying proliferation of donor-derived CD8+ T cells after BMT are still unclear. We investigated whether these CD8+ T cells proliferate in response to specific antigens by determination of TCR clonality and whether these cells exert specific cytotoxicity. PCR analysis of TCR-gamma gene rearrangements showed a marked clonal predominance in CD8+ T cells of recipients with a high number of these cells. Strong association between expansion of CD8+ T cells and CMV infection suggests involvement of CMV antigens. Therefore, we examined CMV-specific cytotoxicity of freshly isolated CD8+ T cells of two BMT recipients with clonal expansion after the onset of CMV infection. CD8+ T cells exerted HLA-restricted cytotoxicity directed against CMV-infected fibroblasts indicating that CMV stimulates proliferation. The majority of CD8+ T cells in these recipients expressed CD57. We demonstrated that TCR clonality was irrespective of CD57 expression. Both CD8+CD57+ and CD8+CD57- T cells showed significant HLA-restricted CMV-specific cytotoxicity. These studies strongly suggest that CMV antigens can induce expansion of clonal CD8+ T cells after BMT.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864444

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Increased activation and oligoclonality of peripheral CD8(+) T cells in the chronic human helminth infection alveolar echinococcosis.

Authors:  Burkhard J Manfras; Stefan Reuter; Thomas Wendland; Peter Kern
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

2.  Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.

Authors:  R M Saliba; K V Komanduri; S Giralt; J de Souza; P Patah; B Oran; D Couriel; G Rondon; R E Champlin; M de Lima
Journal:  Bone Marrow Transplant       Date:  2008-11-17       Impact factor: 5.483

3.  Impact of cytomegalovirus and grafts versus host disease on the dynamics of CD57+CD28-CD8+ T cells after bone marrow transplant.

Authors:  Ana Verena Almeida Mendes; Esper Georges Kallas; Gil Benard; Cláudio Sérgio Pannuti; Reneé Menezes; Frederico Luiz Dulley; Thomas George Evans; Reinaldo Salomão; Clarisse Martins Machado
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

Review 4.  Amplification of autoimmune disease by infection.

Authors:  David N Posnett; Dmitry Yarilin
Journal:  Arthritis Res Ther       Date:  2005-02-10       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.